News & Events

Caligor supporting Puma’s expanded access program for breast cancer therapy

Caligor supporting Puma’s expanded access program for breast cancer therapy

Caligor supporting Puma’s expanded access program for breast cancer therapy

By Melissa Fassbender, 20-Apr-2017

Caligor Opco LLC is providing regulatory and logistical management for Puma Biotechnology’s expanded access program (EAP) for its investigational breast cancer therapy, neratinib.

Back to News & Events